Bionona

BioNona is a pre-clinical stage biotechnology company dedicated to optimizing lipid nanoparticle (LNP) delivery for mRNA and other nucleic acid-based medicines. The company's proprietary technology platform focuses on the design and synthesis of novel ionizable lipids to improve the safety, efficacy, and tissue-specific targeting of genetic therapies. BioNona aims to overcome the current limitations of LNP delivery, particularly the challenges associated with extrahepatic targeting and potential immunogenicity. By engineering specialized delivery vehicles, the company seeks to expand the therapeutic potential of nucleic acid medicines across oncology, infectious diseases, and rare genetic disorders. Based in San Diego, BioNona is led by experts in nanoparticle formulation and lipid chemistry.